Statistics about Health, Pharma & Medtech in United States
Statistics
- Bioxytran total assets 2019-2023
- Bioxytran net cash 2019-2023
- Bioxytran liabilities 2019-2023
- Allovir net cash 2019-2023
- Bioxytran operating profit 2019-2023
- Rapid Therapeutic Science Laboratories, Inc. liabilities 2018-2022
- Allovir total equity 2019-2023
- Biovie total assets 2020-2024
- Biovie total equity 2020-2024
- Biovie liabilities 2020-2024
- Biovie net income 2020-2024
- Biovie net cash 2020-2024
- Rezolute operating profit 2020-2024
- Revance Therapeutics operating profit 2019-2023
- Biora Therapeutics, Inc. total equity 2019-2023
- Biovie operating profit 2020-2024
- Biora Therapeutics, Inc. net cash 2019-2023
- Biora Therapeutics, Inc. total assets 2019-2023
- Biora Therapeutics, Inc. gross profit 2019-2021
- Revolution Medicines operating profit 2019-2023
- Orgenesis liabilities 2019-2023
- Allovir liabilities 2019-2023
- Biora Therapeutics, Inc. operating profit 2019-2023
- Rapid Therapeutic Science Laboratories, Inc. net cash 2015-2022
- Rubius Therapeutics total assets 2018-2022
- Organogenesis Holdings net cash 2019-2023
- Orgenesis net cash 2019-2023
- Respirerx Pharmaceuticals total assets 2018-2022
- Sab Biotherapeutics, Inc. net cash 2020-2023
- Optinose net cash 2019-2023
- Rezolute net cash 2020-2024
- Revance Therapeutics net cash 2019-2023
- Oncternal Therapeutics, Inc. net cash 2019-2023
- Twinlab Consolidated Holdings liabilities 2019-2023
- Cymabay Therapeutics, Inc. total equity 2019-2023
- Revolution Medicines net cash 2019-2023
- Oncorus net cash 2019-2022
- Omega Therapeutics net cash 2020-2023
- Rubius Therapeutics net cash 2018-2022
- Codiak Biosciences, Inc. net income 2019-2021
- Respirerx Pharmaceuticals net cash 2018-2022
- Olema Pharmaceuticals net cash 2019-2023
- Sab Biotherapeutics, Inc. liabilities 2020-2023
- One World Products, Inc. liabilities 2019-2023
- Rezolute liabilities 2020-2024
- Ovid Therapeutics liabilities 2019-2023
- Oncotelic Therapeutics, Inc. liabilities 2010-2023
- Revolution Medicines liabilities 2019-2023
- Ontrak, Inc. liabilities 2019-2023
- Revance Therapeutics liabilities 2019-2023
- Outlook Therapeutics, Inc. liabilities 2019-2023
- Neximmune operating profit 2020-2023
- Rubius Therapeutics liabilities 2018-2022
- Oric Pharmaceuticals liabilities 2019-2023
- Biora Therapeutics, Inc. liabilities 2019-2023
- Rapid Therapeutic Science Laboratories, Inc. operating profit 2014-2016
- Oric Pharmaceuticals net cash 2019-2023
- Biocryst Pharmaceuticals operating profit 2019-2023
- Revolution Medicines revenue 2019-2023
- Sab Biotherapeutics, Inc. revenue 2020-2023
- Revance Therapeutics revenue 2019-2023
- Oncotelic Therapeutics, Inc. operating profit 2019-2023
- Rapid Therapeutic Science Laboratories, Inc. revenue 2018-2022
- Codiak Biosciences, Inc. total equity 2018-2021
- Orgenesis operating profit 2019-2023
- Organogenesis Holdings operating profit 2019-2023
- Oric Pharmaceuticals operating profit 2019-2023
- Respirerx Pharmaceuticals revenue 2010-2015
- Optinose operating profit 2019-2023
- Tonix Pharmaceuticals Holding liabilities 2019-2023
- Alzamend Neuro net income 2022-2023
- Biocryst Pharmaceuticals total equity 2019-2023
- Biocryst Pharmaceuticals net cash 2019-2023
- Ontrak, Inc. operating profit 2019-2023
- Rezolute net income 2020-2024
- Biocryst Pharmaceuticals total assets 2019-2023
- Olema Pharmaceuticals operating profit 2019-2023
- Oncternal Therapeutics, Inc. operating profit 2019-2023
- Codiak Biosciences, Inc. total assets 2019-2021
- Revolution Medicines net income 2019-2023
- Biocryst Pharmaceuticals revenue 2019-2023
- Oncorus operating profit 2019-2022
- Omega Therapeutics operating profit 2020-2023
- Rubius Therapeutics net income 2018-2022
- Rapid Therapeutic Science Laboratories, Inc. net income 2021-2022
- Respirerx Pharmaceuticals net income 2020-2021
- Ontrak, Inc. gross profit 2019-2023
- One World Products, Inc. gross profit 2020-2023
- Outlook Therapeutics, Inc. operating profit 2019-2023
- Biocept Inc liabilities 2018-2022
- Biora Therapeutics, Inc. revenue 2019-2023
- Respirerx Pharmaceuticals operating profit 2018-2022
- Oncorus liabilities 2019-2022
- Oncternal Therapeutics, Inc. liabilities 2022-2023
- Biora Therapeutics, Inc. net income 2019-2022
- Codiak Biosciences, Inc. revenue 2019-2021
- Codiak Biosciences, Inc. liabilities 2019-2021
- Rubius Therapeutics operating profit 2018-2022
- Allovir net income 2019-2023
- Olema Pharmaceuticals liabilities 2020-2023